This article is for informational and educational purposes only and does not replace medical advice from your physician. Women managing both cardiovascular conditions and bladder health concerns should discuss any supplement additions with their cardiologist and urologist. UTCardiothoracicSurgery.com Editorial Team | July 2026. This article may contain affiliate links. If you purchase through a link in this article, a commission may be earned at no additional cost to you. This has no influence on editorial objectivity. FTC disclosure required by 16 C.F.R. Part 255.
Quick Answer: NewEra Primera (also marketed as NewEra Protect) is a plant-based bladder support supplement for women over 40, containing horsetail extract, resveratrol, sumac extract, and Crataeva nurvala. The cardiac safety considerations center on resveratrol's documented cardiovascular effects (antiplatelet activity, blood pressure modulation), horsetail's diuretic properties potentially interacting with prescribed diuretics, and the general caution required when adding herbal supplements to cardiac medication regimens. The product uses a proprietary blend with undisclosed individual ingredient doses.
Bladder Health and Cardiac Medication: The Overlooked Overlap
Urinary incontinence and cardiovascular disease frequently coexist in the same patient population. Women over 60 managing hypertension, heart failure, or post-surgical recovery are commonly prescribed diuretics, which directly affect urinary volume and frequency. Loop diuretics (furosemide) and thiazides (hydrochlorothiazide) increase urine output by design, potentially exacerbating or masking incontinence symptoms. A bladder support supplement entering this medication context creates questions that standard product reviews never raise: Does it interact with diuretics? Does it affect fluid balance? Do its botanical ingredients compound or counteract cardiac medication effects? This review provides that analysis.
Verified Product Details
NewEra Primera (sold as “NewEra Protect” through neweraprotec.com) is a capsule-format dietary supplement marketed for women over 40 experiencing stress incontinence, urge incontinence, and urinary frequency. The formulation contains horsetail extract, resveratrol, sumac extract, and Crataeva nurvala. It is manufactured in a U.S. GMP-certified facility. The product is sold exclusively through the official website. A 90-day money-back guarantee covers both opened and unopened bottles. The manufacturer recommends 4-6 weeks of consistent daily use before expecting noticeable results. Individual ingredient dosages are not publicly disclosed, as the formula uses a proprietary blend.
Marketing Claims Under Scrutiny
NewEra Primera marketing reports customer satisfaction ratings of 4.78-4.97 stars from over 12,800 to 63,500 verified reviews. The UTCTS Desk notes several concerns with these metrics. First, the review count range (12,800 to 63,500) varies substantially across marketing pages, which undermines credibility. Second, these reviews are self-reported on the brand's own platform and are not independently audited. Third, the marketing uses language like “life-changing” and “exceptionally high satisfaction” that exceeds the evidence standard expected for an undisclosed proprietary blend without published clinical trials on the finished formula. The marketing does not address cardiac medication interactions, diuretic effects, or cardiovascular considerations in any visible capacity.
Ingredient Evidence and Dose Analysis
Horsetail Extract (Equisetum arvense): Rich in silica and traditionally used for connective tissue support. Horsetail also has documented diuretic properties, increasing urine output through mechanisms distinct from pharmaceutical diuretics. This creates a paradox for a bladder support product: an ingredient that increases urine volume in a supplement designed to reduce urinary frequency. At low doses, the connective tissue support may predominate; at higher doses, the diuretic effect becomes more relevant. The undisclosed dose prevents assessment of which effect dominates. Clinical evidence for horsetail improving bladder tone is limited to small studies and traditional use data.
Resveratrol: A polyphenol with extensive cardiovascular research. Resveratrol has documented antiplatelet activity, mild blood pressure-lowering effects, and antioxidant properties. Clinical studies on cardiovascular effects typically use 150-500mg daily. In the context of bladder health, resveratrol's anti-inflammatory and tissue-protective properties provide the rationale for inclusion. However, its cardiovascular effects are the primary interaction concern for cardiac patients.
Sumac Extract: Contains tannins and organic acids with anti-inflammatory and antimicrobial properties. Limited pharmacological data exists on cardiac drug interactions. Some sumac species have demonstrated mild blood sugar-lowering effects in preliminary studies.
Crataeva Nurvala: An Ayurvedic botanical with traditional use for urinary tract support. Limited Western clinical data. Some evidence suggests smooth muscle relaxant properties in the bladder wall. No documented cardiovascular drug interactions, though pharmacological data is insufficient for comprehensive assessment.
Cardiac Safety Profile
NewEra Primera's cardiac safety considerations span multiple medication categories:
- Diuretics (furosemide, hydrochlorothiazide, spironolactone): Horsetail's natural diuretic properties may produce additive effects with prescribed diuretics. This could lead to excessive fluid loss, electrolyte imbalances (particularly potassium and magnesium depletion), and dehydration. Electrolyte disturbances can trigger cardiac arrhythmias, particularly in patients with underlying heart disease. Women on diuretics should have their electrolyte levels monitored if they initiate horsetail-containing supplements.
- Warfarin / anticoagulants: Resveratrol has demonstrated antiplatelet activity in multiple studies, inhibiting platelet aggregation through cyclooxygenase and thromboxane pathways. This effect is additive with warfarin and DOACs. INR monitoring is advisable for women on anticoagulant therapy who begin resveratrol-containing supplements.
- Antiplatelet agents (aspirin, clopidogrel): Resveratrol's antiplatelet mechanism is additive. Increased bruising and bleeding risk is plausible.
- Antihypertensives: Resveratrol has mild vasodilatory and blood pressure-lowering effects. Additive hypotension is possible, though likely modest at typical supplement doses.
- Statins: Resveratrol may modestly affect CYP3A4 activity at high doses. Clinical significance with statins is uncertain but theoretically possible for atorvastatin and simvastatin.
- Potassium-sparing diuretics (spironolactone, eplerenone): The interaction between horsetail (which may deplete potassium) and potassium-sparing diuretics (which conserve potassium) creates an unpredictable electrolyte environment. Potassium monitoring is warranted.
- Digoxin: Electrolyte disturbances from additive diuretic effects (particularly hypokalemia) increase digoxin toxicity risk. Women on digoxin should exercise particular caution with horsetail-containing supplements.
- Beta-blockers: No direct interaction established with listed ingredients.
- Diabetes medications: Both resveratrol and sumac have demonstrated mild blood sugar-lowering effects in preliminary research. Additive hypoglycemia risk is possible for diabetic cardiac patients on glucose-lowering therapy.
User-Reported Outcomes
Available reviews describe gradual improvement in bladder control over 4-8 weeks, with users reporting fewer urgency episodes, reduced nighttime bathroom trips, and improved confidence during physical activity. The positive sentiment is consistent across available feedback, though the manufacturer-hosted review platform prevents independent verification. A minority of users report no improvement. Some note mild gastrointestinal effects. No cardiac-specific adverse events are mentioned in available reviews, but the product's primary demographic (women over 40 with incontinence) may have lower rates of complex cardiac medication use than the general cardiac patient population.
Pricing and Refund Terms
NewEra Primera is priced at $79 per single bottle, $59 per bottle in a 3-bottle bundle ($177 total), and $49 per bottle in a 6-bottle bundle ($294 total). Free U.S. shipping is included. The 90-day money-back guarantee covers opened and unopened bottles with refunds processing within 5-7 business days, no restocking fees. The product is available exclusively through neweraprotec.com. Pricing is subject to change. Verify current pricing on the manufacturer's official listing.
Buyer Takeaway
NewEra Primera addresses a legitimate and underserved health concern for women over 40. The individual ingredients have traditional and preliminary scientific support for bladder health, though the complete proprietary formula lacks published clinical trials. For women without cardiovascular conditions or cardiac medications, the risk profile appears modest. For women managing heart disease, the cardiac safety considerations are meaningful: horsetail's diuretic properties create electrolyte and fluid balance concerns for patients on prescribed diuretics or digoxin, resveratrol's antiplatelet activity warrants caution for women on anticoagulants, and the undisclosed proprietary blend doses prevent precise risk quantification. Women on cardiac medications should present the full ingredient list to their cardiologist or pharmacist before beginning this supplement. The 90-day guarantee and the product's exclusive direct-sales model provide reasonable financial protection during a trial period.
Related Reading
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for educational purposes only and does not constitute medical advice. Results vary by individual. Consult your physician before starting any supplement, particularly if you take cardiovascular or metabolic medications.